Compound 114
Identifiers
- Canonical SMILES:
CN1c2ncnn2[C@H](C2=C1c1ccc(F)cc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1
- InChi:
InChI=1S/C25H17Br2FN4O/c1-31-23-19-11-10-18(28)12-20(19)33-24(15-4-8-17(27)9-5-15)21(23)22(32-25(31)29-13-30-32)14-2-6-16(26)7-3-14/h2-13,22,24H,1H3/t22-,24+/m0/s1
- InChiKey:
AIOZGEABJSSJIO-LADGPHEKSA-N
External links
44549894 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 565.98 g/mol | |||
HBA | 5 | |||
HBD | 0 | |||
HBA + HBD | 5 | |||
AlogP | 6.65 | |||
TPSA | 43.18 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4528 | BMS-394136 | DB12067 | |
0.3750 | GDC-0927 | DB14934 | |
0.3656 | Parsaclisib | DB14867 | |
0.3506 | Posaconazole | DB01263 | |
0.3417 | LY-2881835 | DB15046 | |
0.3385 | Naldemedine | DB11691 | |
0.3356 | E-2012 | DB05171 | |
0.3353 | (4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium | DB02673 | |
0.3299 | Rocaglamide | DB15495 | |
0.3297 | Desvancosaminyl vancomycin | DB04529 | |
0.3289 | Galicaftor | DB14894 | |
0.3287 | Monastrol | DB04331 | |
0.3273 | Astemizole | DB00637 | |
0.3271 | Vancomycin | DB00512 | |
0.3246 | MK-1775 | DB11740 |